The glutamine 27 glutamic acid polymorphism of the β 2-adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: A population-based study in Spain

Clinical Endocrinology

Volumn 59, Issue 4, 2003, Pages 476-481

  Gonzalez Sanchez J L ^a   Proenza, A M ^b   Martinez Larrad M T ^a   Ramis, J M ^b   Fernandez Perez C ^a   Palou, A ^b   Serrano Rios M ^a,c  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CHOLESTEROL; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROINSULIN; TRIACYLGLYCEROL;

ADULT; ALLELE; ANTHROPOMETRY; ARTICLE; BIOCHEMISTRY; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE PREDISPOSITION; FEMALE; GENDER; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HETEROZYGOSITY; HOMEOSTASIS; HOMOZYGOSITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SPAIN; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD GLUCOSE; BODY CONSTITUTION; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; GLUCOSE TOLERANCE TEST; GLUTAMIC ACID; GLUTAMINE; HUMANS; INSULIN; LEPTIN; MALE; MIDDLE AGED; OBESITY; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, ADRENERGIC; RECEPTORS, ADRENERGIC, BETA-2; SEX FACTORS;

EID: 0141616466     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01871.x     Document Type: Article

References (25)

1. American Diabetes Association (1998) Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 21 (Suppl. 1), S5-S19.
2. Arner, P. & Hoffstedt, J. (1999) Adrenoceptor genes in human obesity. Journal of Internal Medicine, 245, 667-672.
3. Carlsson, M., Orho-Melander, M., Hedenbro, J. & Groop, L.C. (2001) Common variants in the beta2-(Gln27Glu) and beta3-(Trp64Arg) adrenoceptor genes are associated with elevated serum NEFA concentrations and type II diabetes. Diabetologia, 44, 629-636.
4. Corbalan, M.S., Marti, A., Forga, L., Martinez-Gonzalez, M.A. & Martinez, J.A. (2002) Beta(2)-adrenergic receptor mutation and abdominal obesity risk: effect modification by gender and HDL-cholesterol. European Journal of Nutrition, 41, 114-118.
5. Echwald, S.M., Sorensen, T.I., Tybjaerg-Hansen, A., Andersen, T. & Pedersen, O. (1998) Gln27Glu variant of the human beta2-adrenoreceptor gene is not associated with early-onset obesity in Danish men. Diabetes, 47, 1657-1658.
6. Ehrenborg, E., Skogsberg, J., Ruotolo, G., Large, V., Eriksson, P., Amer, P. & Hamsten, A. (2000) The Q/E27 polymorphism in the beta2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins. Journal of Internal Medicine, 247, 651-656.
7. Green, S.A., Turki, J., Innis, M. & Liggett, S.B. (1994) Amino-terminal polymorpbisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry, 33, 9414-9419.
8. Hayakawa, T., Nagai, Y., Kabara, T., Yamashita, H., Takamura, T., Abe, T., Nomura, G. & Kobayashi, K. (2000) Gln27Glu and Arg 16Gly polymorphisms of the beta2-adrenergic receptor gene are not associated with obesity in Japanese men. Metabolism, 49, 1215-1218.
9. Hellstrom, L., Large, V., Reynisdottir, S., Wahrenberg, H. & Arner, P. (1999) The different effects of a Gln27Glu beta 2-adrenoceptor gene polymorphism on obesity in males and in females. Journal of Internal Medicine, 245, 253-259.
10. Ishiyama-Shigemoto, S., Yamada, K., Yuan, X., Ichikawa, F. & Nonaka, K. (1999) Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia, 42, 98-101.
11. Kawamura, T., Egusa, G., Fujikawa, R. & Okubo, M. (2001) Gln27Glu variant of the beta2-adrenergic receptor gene is not associated with obesity and diabetes in Japanese-Americans. Metabolism, 50, 443-446.
12. Kortner, B., Wolf, A., Wendt, D., Beisiegel, U. & Evans, D. (1999) Lack of association between a human beta-2 adrenoceptor gene polymorphism (Gln27Glu) and morbid obesity. International Journal of Obesity and Related Metabolic Disorders, 23, 1099-1100.
13. Large, V., Hellstrom, L., Reynisdottir, S., Lonnqvist, F., Eriksson, P., Lannfelt, L. & Arner, P. (1997) Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. Journal of Clinical Investigation, 100, 3005-3013.
14. Liggett, S.B. (1997) Polymorphisms of the beta2-adrenergic receptor and asthma. American Journal of Respiratory and Critical Care Medicine, 156, S156-S162.
15. Lorenzo, C., Serrano-Rios, M., Martinez-Larrad, M.T., Gabriel, R., Williams, K., Gonzalez-Villalpando, C., Stern, M.P., Hazuda, H.P. & Haffner, S.M. (2001) Was the historic contribution of Spain to the Mexican gene pool partially responsible for the higher prevalence of type 2 diabetes in Mexican-origin populations? The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study. Diabetes Care, 24, 2059-2064.
16. Macho-Azcarate, T., Marti, A., González, A., Martínez, J.A. & Ibañez, J. (2002) Gln27Glu polymorphism in the beta2 adrenergic receptor gene and lipid metabolism during exercise in obese women. International Journal of Obesity, 26, 1434-1441.
17. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologna, 28, 412-419.
18. Meirhaeghe, A., Helbecque, N., Cottel, D. & Amouyel, P. (2000) Impact of polymorphisms of the human beta2-adrenoceptor gene on obesity in a French population. International Journal of Obesity and Related Metabolic Disorders, 24, 382-387.
19. Oberkofler, H., Esterbauer, H., Hell, E., Krempler, F. & Patsch, W. (2000) The Gln27Glu polymorphism in the beta2-adrenergic receptor gene is not associated with morbid obesity in Austrian women. International Journal of Obesity and Related Metabolic Disorders, 24, 388-390.
20. Palou, A., Serra, F., Bonet, M.L. & Pico, C. (2000) Obesity: molecular bases of a multifactorial problem. European Journal of Nutrition, 39, 127-144.
21. Pi-Sunyer, F.X. (1993) Medical hazards of obesity. Annals of Internal Medicine, 119, 655-660.
22. Proenza, A.M., Poissonnet, C.M., Ozata, M., Ozen, S., Guran, S., Palou, A. & Strosberg, A.D. (2000) Association of sets of alleles of genes encoding beta3-adrenoreceptor, uncoupling protein 1 and lipoprotein lipase with increased risk of metabolic complications in obesity. International Journal of Obesity and Related Metabolic Disorders, 24, 93-100.
23. Sambrook, J., Fritsch, E.F. & Maniatis, T. (1989) Molecular Cloning, pp. 9.14-9.23. Cold Spring Harbor Laboratory Press, New York.
24. Ukkola, O., Rankinen, T., Weisnagel, S.J., Sun, G., Perusse, L., Chagnon, Y.C., Despres, J.P. & Bouchard, C. (2000) Interactions among the alpha2-, beta2-, and beta3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study. Metabolism, 49, 1063-1070.
25. Ukkola, O., Tremblay, A. & Bouchard, C. (2001) Beta-2 adrenergic receptor variants are associated with subcutaneous fat accumulation in response to long-term overfeeding. International Journal of Obesity and Related Metabolic Disorders, 25, 1604-1608.